Virus cocktail targets tough lung bugs in cystic fibrosis trial
Disease control
Recruiting now
This early-stage trial tests a new treatment called AchromoPhage, a mix of four viruses that specifically kill Achromobacter bacteria, in 12 adults with cystic fibrosis and chronic lung infections. Participants will receive the treatment by inhalation, IV, or both over three week…
Phase: PHASE1 • Sponsor: Ghady Haidar • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC